Resistance training and peptides: separating gym lore from evidence

What did @theresistancebarbellclub actually say?

Mark is three weeks into taking what he calls "oil and pet fives" - almost certainly a reference to ipamorelin and CJC-1295 based on context, alongside what he later calls "Somorland," which appears to be a mispronunciation or brand reference to a semaglutide or GH secretagogue compound, possibly MK-677. He reports feeling "a little leaner," losing about a pound, noticing mild muscle definition improvements, sleeping well, but waking up with mild headaches. He attributes those headaches to "your body producing the growth hormone" from the compound. That's his full claim set: modest fat loss, better body composition, good sleep, and headaches explained away as a side effect of GH stimulation.

To be clear about what he did not say: he made no dramatic claims, offered no dosing details, and framed everything cautiously with qualifiers like "I think" and "maybe a little bit." That measured tone is worth noting before we dig into what the science actually shows.

Does the science back this up?

Partly. GH secretagogues like MK-677 do have a real evidence base for improving body composition, though the effect sizes in short trials are modest. The headache-as-GH-signal claim is plausible but oversimplified and not well-supported by clinical literature.

MK-677 (ibutamoren) increases GH and IGF-1 secretion by mimicking ghrelin at the GHS-R1a receptor. A randomized controlled trial by Nass et al. (2008, Annals of Internal Medicine) found that 24 weeks of MK-677 in older adults increased lean body mass and improved sleep quality, particularly slow-wave sleep. Svensson et al. (1998, Journal of Clinical Endocrinology and Metabolism) showed acute GH pulsatility following MK-677 administration in healthy volunteers. So the sleep improvement claim tracks with the pharmacology.

One pound of weight loss over three weeks is extremely modest and could easily be water weight, dietary variation, or measurement error. Claiming this reflects "leaning out" from GH secretagogue activity at three weeks is a stretch. The Nass study required 24 weeks to show lean mass changes. Three weeks is not enough time to draw confident conclusions about body recomposition.

What did they get wrong (or right)?

The headache claim is where things get shaky. Mark says he was told that morning headaches come from "your body producing the growth hormone." This is a popular bro-science explanation that circulates in peptide communities, but it lacks clinical support. Morning headaches are a known side effect of MK-677, but the mechanism is more likely related to fluid retention and increased intracranial pressure, not GH production itself. Fluid retention is a well-documented side effect of GH secretagogues (Nass et al., 2008). Attributing headaches to GH release as though that's a sign the compound is "working" is both inaccurate and potentially dangerous, since persistent morning headaches warrant actual clinical evaluation.

What he got right: his report of improved sleep quality is consistent with the pharmacology. MK-677 enhances slow-wave sleep, which is when endogenous GH secretion peaks anyway. That part of his experience is biologically coherent.

What he got wrong: the headache explanation is folk medicine, not pharmacology. And three weeks of anecdotal body composition changes tells us almost nothing meaningful.

What should you actually know?

GH secretagogues are not approved by the FDA for body composition or anti-aging purposes. MK-677 has been studied in clinical settings for conditions like growth hormone deficiency and muscle wasting, but it is not a regulated therapeutic in the United States for general use. Compounded versions vary substantially in quality, purity, and concentration.

Morning headaches from these compounds are a real signal worth taking seriously, not a badge of efficacy. Fluid retention caused by elevated GH and IGF-1 can increase intracranial pressure, and while mild cases resolve, anyone experiencing persistent morning headaches on a GH secretagogue should consult a clinician before continuing. Self-diagnosing side effects based on advice from "I've been told" sources in the peptide community is exactly the kind of gap that causes real harm.

Body recomposition claims at three weeks are premature by any reasonable standard. If you are evaluating a compound for fat loss or muscle gain, you need at minimum 8-12 weeks of consistent data, controlled diet, and objective measurements, not a mirror check and a rough weight estimate. Mark's honest framing of his experience as tentative is actually more responsible than a lot of peptide content online. But the headache rationalization is a real problem that should not go unchallenged.